NVAX
NASDAQ · Biotechnology
Novavax Inc
$9.53
-0.55 (-5.46%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+203.0% upside
Low Target
$20.35
Average Target
$28.88
High Target
$29.25
Current Price
$9.53
Current
$9.53
$9.53
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Scenario Analysis
Bear Case
$20.35
113.5%
Low target
Base Case
$28.88
+203.0%
Avg target
Bull Case
$29.25
+206.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$13.39
-28.8% from high
52-Week Low
$6.20
+53.7% from low
Target vs 52W High
$28.88
+115.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |